Litigator of the Week Honors for Patent Trial Success
August 12, 2022
Matthew Murphy was honored in The American Lawyer’s “Litigator of the Week” column for Axinn’s trial success on behalf of Alvogen affiliate Norwich Pharmaceuticals in its defense of patent claims asserted by Bausch Health subsidiary Salix Pharmaceuticals. The column noted that the “key ruling” for Norwich, which is seeking to market a generic version of Salix’s blockbuster product Xifaxan®, led to a halt in trading of Bausch Health stock, which dropped more than 50% after news of the judge’s decision. The “Litigator of the Week” feature focuses on cases with “high stakes, long odds,” and “an impact, where the outcome matters to more than just the parties involved.”
Other key members of Axinn’s trial team include Matt Becker, Aziz Burgy, Rebecca Clegg, Ricky Camposanto, and Chantelle Ankerman.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
The 32nd Annual Marketing Partner Forum
Event
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
Client Alerts
Antitrust
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Awards & Recognitions
Antitrust
Merger Remedies Back in Vogue Under Trump
Media Mentions
Antitrust
Three Takeaways from the Initial Determination at the ITC Regarding Standard Essential Patents in the 1380 Investigation
Axinn Viewpoints
Intellectual Property
A POSA’s Motivation Is Not Required To Be the Same as the Inventor’s in Evaluating Obviousness
Axinn Viewpoints
Intellectual Property